Visa to Buy BioCatch

Visa Inc. said on Aug. 3, 2026, it signed a definitive agreement to acquire BioCatch Ltd. for $2.4 billion in cash, aiming to strengthen its fraud detection and cybersecurity offerings.

Deal Terms and Timeline

Visa (NYSE: V) will acquire BioCatch Ltd. in an all-cash transaction. The sellers include funds advised by Permira and other shareholders; Permira described the sale as the full realization of its investment. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close by the end of Visa’s fiscal second quarter of 2027.

Technology, Customers, and Integration

BioCatch provides behavioral-first, multi-signal fraud intelligence designed to detect scams, account takeovers, and digital fraud proactively. Its technology uses behavioral biometrics—analyzing typing cadence, touchscreen swipes, device handling, and other digital signals—to distinguish legitimate users from fraudsters and automated attacks. Founded in 2011, BioCatch protects about 1.8 billion devices and 760 million users worldwide. It serves more than 350 banking customers across 21 countries, including over 100 of the world’s largest banks.

Visa said BioCatch’s expertise will help detect fraud before it happens for financial institutions, consumers, and the payments industry. BioCatch will continue operating as a standalone business within Visa’s Value-Added Services organization, retaining its leadership team and reporting structure. BioCatch CEO Gadi Mazor wrote, "Post-acquisition, we will continue to operate as we have, but now as part of Visa."

The acquisition fits Visa’s broader security strategy. The company has invested more than $13 billion over five years in technology and infrastructure to secure the payments ecosystem. This deal advances Visa’s shift into value-added services beyond traditional transaction fees and enhances its fraud detection capabilities for issuers and networks.